COMPANY

Silver Creek Pharmaceuticals

HQ: South San Francisco, CA source · silvercreekpharma.com ↗ · West Coast

Keywords: protein therapeutics Acute Ischemic Stroke

Location: South San Francisco, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Oct 19, 2022 Trial start Phase 2: Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT05585606	Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke	Phase 2	Completed	Oct 19, 2022	Sep 15, 2025 (actual)

Annual award amounts. Total $221K.

Mar 3, 2015 NIH award 1R43HL124678-01A1 FY2015: $221,242 awarded for that fiscal year; activity R43 (SBIR); PI ONSUM, MATTHEW; recipient as written: SILVER CREEK PHARMACEUTICALS, INC., SAN FRANCISCO, CA. Protein Therapeutics Eng source ↗